XML 33 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Statements of Changes in Equity - BRL (R$)
R$ in Thousands
Total
Share capital
Equity instrument granted
Capital reserve
Treasury shares
Revaluation reserve on subsidiaries
Legal Reserves
Investments statutory reserve
Valuation Adjustments
Cumulative translation adjustments
Retained earnings
Additional dividends to the minimum mandatory dividends
Shareholders of the Company
Non-controlling interests in subsidiaries
Beginning balance at Dec. 31, 2017 R$ 9,624,038 R$ 5,171,752 R$ 536 R$ 549,778 R$ (482,260) R$ 4,930 R$ 629,144 R$ 3,000,707 R$ 154,824 R$ 53,061   R$ 163,742 R$ 9,246,214 R$ 377,824
Statement [Line Items]                            
Net income for the year 1,132,320                   R$ 1,150,421   1,150,421 (18,101)
Actuarial (gain) losses of post-employment benefits, net of income taxes:                            
Subsidiaries (5,282)                          
Actuarial losses of post-employment benefits, net of income taxes (6,657)               (2,568)       (2,568) (4,089)
Fair value adjustments of financial assets, net of income taxes (216,266)               (216,245)       (216,245) (21)
Currency translation of foreign subsidiaries, including the effect of net investments hedge 12,796                 12,796     12,796  
Total comprehensive income for the year 922,193               (218,813) 12,796 1,150,421   944,404 (22,211)
Stock plan (10,501)     (7,378) (3,123)               (10,501)  
Equity instrument granted 3,773   3,773                   3,773  
Realization of revaluation reserve of subsidiaries           (218)         218      
Income and social contribution taxes on realization of revaluation reserve of subsidiaries (3)                   (3)   (3)  
Expired dividends 3,170                   3,170   3,170  
Transfer to investments reserve               3,385     (3,385)      
Additional dividends attributable to non-controlling interests (3,689)                         (3,689)
Transfer to statutory reserve               408,335     (408,335)      
Approval of additional dividends by the Shareholders' Meeting (163,742)                     (163,742) (163,742)  
Allocation of net income:                            
Legal reserve             57,521       (57,521)      
Interim dividends (R$ 0.56 per share of the Company) (304,241)                   (304,241)   (304,241)  
Proposed dividends (R$ 0.70 per share of the Company) (270,969)                   (380,324) 109,355 (270,969)  
Ending balance at Dec. 31, 2018 9,800,029 5,171,752 4,309 542,400 (485,383) 4,712 686,665 3,412,427 (63,989) 65,857   109,355 9,448,105 351,924
Statement [Line Items]                            
Net income for the year 402,944                   373,526   373,526 29,418
Fair value adjustments of available for financial instruments, net of income taxes:                            
Subsidiaries (51,319)               (51,340)       (51,340) 21
Joint ventures (978)               (978)       (978)  
Actuarial (gain) losses of post-employment benefits, net of income taxes:                            
Subsidiaries (29,996)                          
Actuarial losses of post-employment benefits, net of income taxes (36,787)               (30,010)       (30,010) (6,777)
Currency translation of foreign subsidiaries, including the effect of net investments hedge 36,570                 36,570     36,570  
Total comprehensive income for the year 350,430               (82,328) 36,570 373,526   327,768 22,662
Equity instrument granted of subsidiaries 7,661   7,661                   7,661  
Shareholder transaction—gain in reimbursement of shares pref. B from Oxiteno Nordeste                     1,489   1,489 (1,489)
Realization of revaluation reserve of subsidiaries           (190)         190      
Income and social contribution taxes on realization of revaluation reserve of subsidiaries (31)                   (31)   (31)  
Transfer to investments reserve               1,648     (1,648)      
Dividends attributable to non-controlling interests (993)                         (993)
Redemption of non-controlling shares of Oxiteno Nordeste (2,180)                         (2,180)
Capital increase from subsidiary Iconic non-controlling shareholders 6,996                         6,996
Approval of additional dividends by the Shareholders' Meeting (109,355)                     (109,355) (109,355)  
Allocation of net income:                            
Legal reserve             18,676       (18,676)      
Interim dividends (R$ 0.20 per share of the Company) (217,382)                   (217,382)   (217,382)  
Proposed dividends (R$ 0.24 per share of the Company)               (124,002)     (137,468) 261,470    
Ending balance at Dec. 31, 2019 9,835,175 5,171,752 11,970 542,400 (485,383) 4,522 705,341 3,290,073 (146,317) 102,427   261,470 9,458,255 376,920
Statement [Line Items]                            
Net income for the year 927,697                   893,383   893,383 34,314
Fair value adjustments of available for financial instruments, net of income taxes:                            
Subsidiaries (313,271)               (313,271)       (313,271)  
Joint ventures 190               190       190  
Actuarial (gain) losses of post-employment benefits, net of income taxes:                            
Subsidiaries (17,762)               (6,467)       (6,467) (11,295)
Joint ventures 875               875       875  
Currency translation of foreign subsidiaries, including the effect of net investments hedge 129,169                 129,169     129,169  
Total comprehensive income for the year 726,898               (318,673) 129,169 893,383   703,879 23,019
Issuance of shares related to the subscription warrants - indemnification - Extrafarma acquisition 54,763     54,763                 54,763  
Stock plan (6,799)     (3,114) (3,685)               (6,799)  
Equity instrument granted 4,526   4,526                   4,526  
Equity instrument granted of subsidiaries 5,908   5,908                   5,908  
Income and social contribution taxes on realization of revaluation reserve of subsidiaries           (185)         185      
Transfer to investments reserve               (774)     774      
Loss due to the payments fixed dividends to preferred shares                     (1,001)   (1,001) 1,001
Shareholder transaction – changes of investments                     42   42 (42)
Dividends attributable to non-controlling interests (24,379)                         (24,379)
Approval of additional dividends by the Shareholders' Meeting (261,470)                     (261,470) (261,470)  
Allocation of net income:                            
Legal reserve             44,669       (44,669)      
Investments statutory reserve               368,966     (368,966)      
Proposed dividends (R$ 0.44 per share) (424,357)                   R$ (479,748) 55,391 (424,357)  
Ending balance at Dec. 31, 2020 R$ 9,910,265 R$ 5,171,752 R$ 22,404 R$ 594,049 R$ (489,068) R$ 4,337 R$ 750,010 R$ 3,658,265 R$ (464,990) R$ 231,596   R$ 55,391 R$ 9,533,746 R$ 376,519